Clinical Trial Update: Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the comparative bioavailability of 600 mg azithromycin monohydrate tablets under fasting conditions and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection

Drugs mentioned

• Azithromycin monohydrate 600 mg tablets (Azithromycin)

Snippet

Sponsor: Sandoz | Conditions: Infection | Phase 1 | Status: COMPLETED